tiprankstipranks
Trending News
More News >
Delta-Fly Pharma, Inc. (JP:4598)
:4598
Japanese Market
Advertisement

Delta-Fly Pharma, Inc. (4598) Drug Pipeline

Compare
0 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Venetoclax, Dfp-10917
Leukemia, Myeloid, Acute
Phase I/II
Recruiting
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Apr 19, 2024
Dfp-14927
Cancer, Solid Tumor
Phase I
Recruiting
Trial of DFP-14927 in Advanced Solid Tumors
Apr 25, 2019
Fludarabine, Azacitidine, Cytarabine, Decitabine, Venetoclax, Etoposide, Idarubicin, Mitoxantrone, Dfp-10917, Cladribine
Leukemia, Myeloid, Acute
Phase III
Recruiting
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Apr 11, 2019

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Delta-Fly Pharma, Inc. (4598) have in its pipeline
      4598 is currently developing the following drugs: Venetoclax, Dfp-10917, Dfp-14927, Fludarabine, Azacitidine, Cytarabine, Decitabine, Venetoclax, Etoposide, Idarubicin, Mitoxantrone, Dfp-10917, Cladribine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis